Literature DB >> 21987749

Risk factors for Zaire ebolavirus--specific IgG in rural Gabonese populations.

Dieudonne Nkoghe1, Cindy Padilla, Pierre Becquart, Nadia Wauquier, Ghislain Moussavou, Jean Paul Akué, Benjamin Ollomo, Xavier Pourrut, Marc Souris, Mirdad Kazanji, Jean-Paul Gonzalez, Eric Leroy.   

Abstract

BACKGROUND: In Gabon, several Ebolavirus outbreaks have occurred exclusively in the northeastern region. We conducted a large serosurvey to identify areas and populations at risk and potential demographic, clinical, and behavioral risk factors.
METHODS: Blood samples and clinical and sociodemographic data were collected from 4349 adults and 362 children in a random sample of 220 villages in the 9 provinces of Gabon. An enzyme-linked immunosorbent assay was used to detect Zaire ebolavirus (ZEBOV)-specific IgG, and thin blood smears were used to detect parasites. Logistic regression was implemented using Stata software (Stata), and a probability level of <.05 was considered to be statistically significant.
RESULTS: The prevalence of ZEBOV-specific IgG was 15.3% overall, increasing to 32.4% (P< .001) in forest areas. No sociodemographic risk factors were found, but the antibody prevalence increased linearly up to 20 years of age. Chronic arthralgia and amicrofilaremia were the only factors associated with ZEBOV seropositivity.
CONCLUSIONS: These findings confirm the endemicity of ZEBOV in Gabon and its link to the ecosystem. Human antibody positivity would appear to be to the result of exposure to contaminated fruits.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21987749     DOI: 10.1093/infdis/jir344

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

Review 1.  Gastrointestinal and Hepatic Manifestations of Ebola Virus Infection.

Authors:  Nisha Sharma; Mitchell S Cappell
Journal:  Dig Dis Sci       Date:  2015-05-14       Impact factor: 3.199

2.  Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo.

Authors:  Anna Bratcher; Nicole A Hoff; Reena H Doshi; Adva Gadoth; Megan Halbrook; Patrick Mukadi; Kamy Musene; Benoit Ilunga-Kebela; D'Andre Spencer; Matthew S Bramble; David McIlwan; J Daniel Kelly; Daniel Mukadi; Placide Mbala Kingebeni; Steve Ahuka; Emile Okitolonda-Wemakoy; Jean-Jacques Muyembe-Tamfum; Anne W Rimoin
Journal:  PLoS Negl Trop Dis       Date:  2021-08-12

3.  Risk Factors Associated with Ebola and Marburg Viruses Seroprevalence in Blood Donors in the Republic of Congo.

Authors:  Nanikaly Moyen; Laurence Thirion; Petra Emmerich; Amelia Dzia-Lepfoundzou; Hervé Richet; Yannik Boehmann; Yannick Dimi; Pierre Gallian; Ernest A Gould; Stephan Günther; Xavier de Lamballerie
Journal:  PLoS Negl Trop Dis       Date:  2015-06-05

Review 4.  Presence and Persistence of Ebola or Marburg Virus in Patients and Survivors: A Rapid Systematic Review.

Authors:  Julii Brainard; Katherine Pond; Lee Hooper; Kelly Edmunds; Paul Hunter
Journal:  PLoS Negl Trop Dis       Date:  2016-02-29

Review 5.  How severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalence.

Authors:  Luke Nyakarahuka; Clovice Kankya; Randi Krontveit; Benjamin Mayer; Frank N Mwiine; Julius Lutwama; Eystein Skjerve
Journal:  BMC Infect Dis       Date:  2016-11-25       Impact factor: 3.090

6.  A framework for the study of zoonotic disease emergence and its drivers: spillover of bat pathogens as a case study.

Authors:  James L N Wood; Melissa Leach; Linda Waldman; Hayley Macgregor; Anthony R Fooks; Kate E Jones; Olivier Restif; Dina Dechmann; David T S Hayman; Kate S Baker; Alison J Peel; Alexandra O Kamins; Jakob Fahr; Yaa Ntiamoa-Baidu; Richard Suu-Ire; Robert F Breiman; Jonathan H Epstein; Hume E Field; Andrew A Cunningham
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-10-19       Impact factor: 6.237

7.  High prevalence of IgG antibodies to Ebola virus in the Efé pygmy population in the Watsa region, Democratic Republic of the Congo.

Authors:  Sabue Mulangu; Matthias Borchert; Janusz Paweska; Antoine Tshomba; Afongenda Afounde; Amayo Kulidri; Robert Swanepoel; Jean-Jacques Muyembe-Tamfum; Patrick Van der Stuyft
Journal:  BMC Infect Dis       Date:  2016-06-10       Impact factor: 3.090

Review 8.  Risk factors for transmission of Ebola or Marburg virus disease: a systematic review and meta-analysis.

Authors:  Julii Brainard; Lee Hooper; Katherine Pond; Kelly Edmunds; Paul R Hunter
Journal:  Int J Epidemiol       Date:  2015-11-20       Impact factor: 7.196

Review 9.  Ocular Manifestations of Ebola Virus Disease: An Ophthalmologist's Guide to Prevent Infection and Panic.

Authors:  Enzo Maria Vingolo; Giuseppe Alessio Messano; Serena Fragiotta; Leopoldo Spadea; Stefano Petti
Journal:  Biomed Res Int       Date:  2015-10-18       Impact factor: 3.411

10.  City-Specific Spatiotemporal Infant and Neonatal Mortality Clusters: Links with Socioeconomic and Air Pollution Spatial Patterns in France.

Authors:  Cindy M Padilla; Wahida Kihal-Talantikit; Verónica M Vieira; Séverine Deguen
Journal:  Int J Environ Res Public Health       Date:  2016-06-22       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.